Analyst Rating: Will Cocrystal Pharma Inc (COCP) Stock Outperform the Market?

Thursday, August 12, 2021 10:43 AM | InvestorsObserver Analysts

Mentioned in this article

Wall Street is positive on Cocrystal Pharma Inc (COCP). On average, analysts give COCP a Strong Buy rating. The average price target is $4.5, which means analysts expect the stock to increase by 324.53% over the next twelve months. That average ranking earns COCP an Analyst Rating of 75, which is better than 75% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating COCP a Strong Buy today. Find out what this means to you and get the rest of the rankings on COCP!
See Full COCP Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Cocrystal Pharma Inc Stock Today?

Cocrystal Pharma Inc (COCP) stock is unmoved 0% while the S&P 500 is lower by -0.08% as of 10:39 AM on Thursday, Aug 12. COCP is flat $0.00 from the previous closing price of $1.06 on volume of 218,176 shares. Over the past year the S&P 500 has gained 31.47% while COCP is lower by -47.00%. COCP lost -$0.17 per share the over the last 12 months. Click Here to get the full Stock Report for Cocrystal Pharma Inc stock.

Share this article:

Related Articles